A Review of Extraction and Purification, Biological Properties, Structure–Activity Relationships and Future Prospects of Schisandrin C: A Major Active Constituent of Schisandra Chinensis
-
Published:2023-12
Issue:12
Volume:20
Page:
-
ISSN:1612-1872
-
Container-title:Chemistry & Biodiversity
-
language:en
-
Short-container-title:Chemistry & Biodiversity
Author:
Xu Hao‐Nan1ORCID,
Wang Wei1ORCID,
Li Xin‐Zhuo1ORCID,
Sun Yu1ORCID,
Li Yu‐Ze1ORCID,
Deng Chong1ORCID,
Song Xiao‐Mei1ORCID,
Zhang Dong‐Dong1ORCID
Affiliation:
1. School of Pharmacy Shaanxi University of Chinese Medicine 712046 Xianyang Shaanxi P. R. China
Abstract
AbstractSince ancient times, China has used natural medicine as the primary way to combat diseases and has a rich arsenal of natural medicines. With the progress of the times, the extraction of bioactive molecules from natural drugs has become the new development direction for natural medicines. Among the numerous natural drugs, Schisandrin C (Sch C), derived from Schisandra Chinensis (Turcz.) Baill. It has excellent potential for development and has been shown to possess various pharmacological properties, including hepatoprotective, antitumor and anti‐inflammatory activities. Based on the biological properties of hepatoprotection, scholars have explored Sch C and its synthetic products in depth; some studies have shown that pentosidine has the effect of improving the symptoms of liver fibrosis and reducing the concentration of alanine transaminase (ALT) and aspartate aminotransferase (AST) in the serum of rats, which is an essential inspiration for the development of anti‐liver fibrosis drugs. But more in vivo and ex vivo studies still need to be included. This paper focuses on Sch C′s extraction and synthesis, biological activities and drug development progress. The future application prospects of Sch C are discussed to perfect its development work further.
Funder
National Natural Science Foundation of China
Shaanxi University of Chinese Medicine
Subject
Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering
Reference106 articles.
1. L. X. Yu D. M. Yan X. F. Xu X. Lin Z. Guan Heilongjiang Med. Pharmacy.2016 39 32+35.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献